Janney Montgomery Scott
PCRX icon

Janney Montgomery Scott’s Pacira BioSciences PCRX Stock Holding History

Janney Montgomery Scott’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-29,395
Closed -$554K – 2819
2024
Q4 		$554K Sell
29,395
-23,313
-44% -$409K ﹤0.01% 1923
2024
Q3 		$793K Buy
+52,708
New +$901K ﹤0.01% 1656
2022
Q2 		– Sell
-2,630
Closed -$201K – 2406
2022
Q1 		$201K Buy
+2,630
New +$175K ﹤0.01% 2099
2016
Q2 		– Sell
-5,850
Closed -$310K – 1027
2016
Q1 		$310K Buy
5,850
+186
+3% +$10.9K 0.01% 950
2015
Q4 		$435K Buy
5,664
+614
+12% +$34.8K 0.01% 883
2015
Q3 		$208K Hold
5,050
– – 0.01% 1233
2015
Q2 		$357K Buy
5,050
+650
+15% +$51.2K 0.01% 1382
2015
Q1 		$391K Buy
4,400
+950
+28% +$96.4K 0.01% 1547
2014
Q4 		$306K Sell
3,450
-50
-1% -$4.73K 0.01% 1681
2014
Q3 		$339K Hold
3,500
– – 0.01% 1552
2014
Q2 		$322K Buy
3,500
+300
+9% +$22.8K 0.01% 1569
2014
Q1 		$224K Buy
+3,200
New +$218K 0.01% 1686

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Janney Montgomery Scott's PCRX Position: Q1 2025 in Review

Janney Montgomery Scott sold out of Pacira BioSciences (PCRX) in Q1 2025, closing a stake of 29,395 shares — an estimated $554K sold.

Janney Montgomery Scott first reported a position in PCRX in Q1 2014 and held it in 12 quarters. The position peaked at $793K in Q3 2024. 235 funds tracked by Wall St. Rank hold PCRX as of Q1 2025.

  • Janney Montgomery Scott reported no remaining Pacira BioSciences position as of Q1 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 29,395 Pacira BioSciences shares in Q1 2025, an estimated $554K.
  • Janney Montgomery Scott first reported a position in Pacira BioSciences in Q1 2014 and held it in 12 quarters.
  • Janney Montgomery Scott's Pacira BioSciences position peaked at $793K in Q3 2024.
  • 235 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2025.

Based on Janney Montgomery Scott's 13F filing for Q1 2025, filed 17 Apr 2025.